phases
INSPECTING INDUSTRIAL COMPONENTS
PRODUCING Medical isotopes
RECYCLING nuclear waste
GENERATING fusion energy
why fusion?
about
company
meet the team
insights and updates
Our Culture
careers
contact
flare sales
isotope sales
phases
INSPECTING INDUSTRIAL COMPONENTS
PRODUCING Medical isotopes
RECYCLING nuclear waste
GENERATING fusion power
//
why fusion?
//
About
Meet the team
Insights & Updates
Our Culture
careers
//
Product & Services
Ilumira - Isotope Sales
FLARE - RADIation effects testing sales
//
contact
//
SHINE Technologies and Nucleus RadioPharma Partner to Advance Radioligand Cancer Treatments
Press Releases
SHINE Technologies and Nucleus RadioPharma Partner to Advance Radioligand Cancer Treatments
No items found.
Lutetium-177 Information Sheet (EU Distribution)
Ilumira Information Sheet
download PDF RESOURCE HERE
Share This Story, Choose
Your Platform!
Share These Events,
Choose Your Platform!
Related Content
SHINE Technologies and Curadh MTR Announce Expanded Strategic Partnership to Advance Cancer Therapies Using Terbium and Lutetium
SHINE to Open North America's Largest Lu-177 Production Facility
SHINE Technologies Raises $70 Million Financing Round to Accelerate the Commercialization of Near-Term Applications of Fusion Technology
